Improving the detection of subtle IKr-Inhibition -: Assessing Electrocardiographic abnormalities of repolarization induced by moxifloxacin

被引:22
作者
Couderc, Jean-Philippe [1 ]
McNitt, Scott [1 ]
Hyrien, Ollivier [2 ]
Vaglio, Martino [1 ]
Xia, Xiajuan [1 ]
Polonsky, Slava [1 ]
Moss, Arthur J. [1 ]
Zareba, Wojciech [1 ]
机构
[1] Univ Rochester, Med Ctr, Dept Cardiol, Heart Res Follow Up Program, Rochester, NY 14642 USA
[2] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY USA
关键词
D O I
10.2165/00002018-200831030-00006
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: QT prolongation is an incomplete measure of drug-induced changes in repolarization. In this study, we investigated a novel, automatic ECG technique for describing ventricular repolarization morphology and we compared these results to corrected QT (QTc) prolongation for identifying ECGs of healthy individuals on moxifloxacin. Methods: We analysed data from the US FDA ECG Warehouse involving 160 standard ECGs from 40 healthy subjects enrolled in a randomized, parallel, placebo-controlled, 'thorough QT' study. Computerized ECG analysis included a series of scalar and vectorial parameters describing duration of repolarization segments and T-wave/loop morphology including its symmetry, amplitude and shape. Binary logistic models for the identification of moxifloxacin-induced abnormalities of the repolarization were developed. Results: Moxifloxacin induced significant changes in several ECG parameters including QT and QT apex and early repolarization duration (ERD)30%, T-wave amplitude and slopes of the ascending and descending arm of the T-wave. The logistic model based only on T-wave morphology parameters outperformed the model based on QTc interval for identifying the presence of moxifloxacin. Combining information about repolarization interval duration with T-wave morphology significantly improved the detection of presence of moxifloxacin (p < 0.01). The increased sensitivity of our novel ECG method contributes to a >40% reduction in the sample size required to detect significant QTc prolongation induced by moxifloxacin. Conclusions: Repolarization morphology is significantly altered by moxifloxacin. The computerized ECG technique provides a novel method for quantifying morphological changes of repolarization segment. Our new parameters reflecting the morphology of the T-wave outperformed QTc measurements when identifying moxifloxacin-induced blockade of the outward rapid components of the delayed rectifier repolarizing potassium current (IKr). These data indicate that the analysis of T-wave morphology could play a role in the assessment of drug toxicity.
引用
收藏
页码:249 / 260
页数:12
相关论文
共 28 条
[1]   Mechanism of hERG K+ channel blockade by the fluoroquinolone antibiotic moxifloxacin [J].
Alexandrou, Ari J. ;
Duncan, Rona S. ;
Sullivan, Anneli ;
Hancox, Jules C. ;
Leishman, Derek J. ;
Witchel, Harry J. ;
Leaney, Joanne L. .
BRITISH JOURNAL OF PHARMACOLOGY, 2006, 147 (08) :905-916
[2]   Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes [J].
Antzelevitch, C ;
Sun, ZQ ;
Zhang, ZQ ;
Yan, GX .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 28 (07) :1836-1848
[3]   Drugs, hERG and sudden death [J].
Brown, AM .
CELL CALCIUM, 2004, 35 (06) :543-547
[4]  
CAMM AJ, 2005, ACQUIRED LONG QT SYN, P8
[5]   QT prolongation and proarrhythmia by moxifloxacin: concordance of preclinical models in relation to clinical outcome [J].
Chen, X ;
Cass, JD ;
Bradley, JA ;
Dahm, CM ;
Sun, ZQ ;
Kadyszewski, E ;
Engwall, MJ ;
Zhou, J .
BRITISH JOURNAL OF PHARMACOLOGY, 2005, 146 (06) :792-799
[6]   Repolarization morphology in adult LQT2 carriers with borderline prolonged QTc interval [J].
Couderc, Jean-Philippe ;
McNitt, Scott ;
Xia, Jean ;
Zareba, Wojciech ;
Moss, Arthur J. .
HEART RHYTHM, 2006, 3 (12) :1460-1466
[7]   Identification of sotalol-induced changes in repolarization with T wave area-based repolarization duration parameters [J].
Couderc, JP ;
Zareba, W ;
Moss, AJ ;
Sarapa, N ;
Morganroth, J ;
Darpo, B .
JOURNAL OF ELECTROCARDIOLOGY, 2003, 36 :115-120
[8]  
COUDERC JP, 2006, ELECTROCARDIOGRAPHIC, P4010
[9]  
COUDERC JP, 2003, INT J BIOELECTROMAGN, P167
[10]   Moxifloxacin: Clinical efficacy and safety [J].
Culley, CM ;
Lacy, MK ;
Klutman, N ;
Edwards, B .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (05) :379-388